These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29853942)

  • 1. Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide.
    Choi JE; Kwak Y; Huh JW; Yoo ES; Ryu KH; Sohn S; Hong YM
    Korean J Pediatr; 2018 May; 61(5):167-173. PubMed ID: 29853942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of ultrasound coronary parameters and blood red cell distribution width and N-terminal pro-brain natriuretic peptide concentrations following coronary lesions in children with Kawasaki disease.
    Gao W; Chen Z; Lu Y; Bai X; Chen M; Lu Y
    Br J Hosp Med (Lond); 2024 Aug; 85(8):1-10. PubMed ID: 39212580
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical characteristics of hemophagocytic lymphohistiocytosis related to Kawasaki disease.
    Kim HK; Kim HG; Cho SJ; Hong YM; Sohn S; Yoo ES; Chung WS; Ryu KH
    Pediatr Hematol Oncol; 2011 Apr; 28(3):230-6. PubMed ID: 21381871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and N-terminal pro-brain natriuretic peptide discrepancy: a differentiation of adenoviral pharyngoconjunctival fever from Kawasaki disease.
    Choi JE; Kang HW; Hong YM; Sohn S
    Korean J Pediatr; 2018 Jan; 61(1):12-16. PubMed ID: 29441107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Jung JY; Ham EM; Kwon H; Kwak YH; Kim DK; Lee JH; Jung JH
    Am J Emerg Med; 2019 Mar; 37(3):468-471. PubMed ID: 29903669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease.
    Kang HR; Kwon YH; Yoo ES; Ryu KH; Kim JY; Kim HS; Kim HM; Lee YH
    Blood Res; 2013 Dec; 48(4):254-7. PubMed ID: 24466549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
    Dionne A; Meloche-Dumas L; Desjardins L; Turgeon J; Saint-Cyr C; Autmizguine J; Spigelblatt L; Fournier A; Dahdah N
    Pediatr Int; 2017 Mar; 59(3):265-270. PubMed ID: 27589358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K; Wakejima Y; Gau M; Kiguchi T; Matsuda N; Takasawa R; Takasawa K; Nishioka M; Shimohira M
    Int J Rheum Dis; 2018 Mar; 21(3):746-754. PubMed ID: 29105337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease.
    Jun H; Ko KO; Lim JW; Yoon JM; Lee GM; Cheon EJ
    Korean J Pediatr; 2016 Jul; 59(7):298-302. PubMed ID: 27588030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Function in Kawasaki Disease Patients with Respiratory Symptoms.
    Lee SB; Choi HS; Son S; Hong YM
    Korean Circ J; 2015 Jul; 45(4):317-24. PubMed ID: 26240586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood N-terminal Pro-brain Natriuretic Peptide and Interleukin-17 for Distinguishing Incomplete Kawasaki Disease from Infectious Diseases.
    Wu L; Chen Y; Zhong S; Li Y; Dai X; Di Y
    Indian Pediatr; 2015 Jun; 52(6):477-80. PubMed ID: 26121721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveitis as an important ocular sign to help early diagnosis in Kawasaki disease.
    Choi HS; Lee SB; Kwon JH; Kim HS; Sohn S; Hong YM
    Korean J Pediatr; 2015 Oct; 58(10):374-9. PubMed ID: 26576181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.
    Lee SH; Song ES; Yoon S; Hong S; Cho HJ; Yang EM; Eom GH; Kang G; Cho YK
    Dis Markers; 2017; 2017():6263121. PubMed ID: 29358841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
    Kwon H; Lee JH; Jung JY; Kwak YH; Kim DK; Jung JH; Chang I; Kim K
    Eur J Pediatr; 2016 Dec; 175(12):1997-2003. PubMed ID: 27798729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between marked hyperferritinemia and hemophagocytic lymphohistiocytosis].
    Gao WB; Shi MJ; Zhang HY; Wu CB; Zhu JH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):921-927. PubMed ID: 34650295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and serum N-terminal pro-brain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age.
    Bae HK; Lee DK; Kwon JH; Kim HS; Sohn S; Hong YM
    Korean J Pediatr; 2014 Aug; 57(8):357-62. PubMed ID: 25210523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease.
    Yanagisawa D; Ayusawa M; Kato M; Watanabe H; Komori A; Abe Y; Nakamura T; Kamiyama H; Takahashi S
    Pediatr Int; 2016 Nov; 58(11):1105-1111. PubMed ID: 26991905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.